home / stock / biovf / biovf quote
Last: | $25.204 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $25.204 |
High: | $0 |
Low: | $0 |
Volume: | 3 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$25.204 | $0 | $25.204 | $0 | $0 | 3 | 07-18-2024 |
$25.204 | $25.204 | $25.204 | $25.204 | $25.204 | 138 | 07-17-2024 |
$26.51 | $0 | $26.51 | $0 | $0 | 711 | 07-12-2024 |
$26.51 | $0 | $26.51 | $0 | $0 | 14 | 07-10-2024 |
$26.51 | $0 | $26.51 | $0 | $0 | 25 | 07-05-2024 |
$26.51 | $26.51 | $26.51 | $26.51 | $26.51 | 500 | 07-02-2024 |
$26.955 | $0 | $26.955 | $0 | $0 | 73 | 07-01-2024 |
$26.955 | $26.955 | $26.955 | $26.955 | $26.955 | 603 | 06-28-2024 |
$27.5369 | $27.5369 | $27.5369 | $27.5369 | $27.5369 | 907 | 06-25-2024 |
$26.33 | $0 | $26.33 | $0 | $0 | 16 | 06-20-2024 |
$26.33 | $26.33 | $26.33 | $26.33 | $26.33 | 300 | 06-13-2024 |
$26.36 | $26.36 | $26.36 | $26.36 | $26.36 | 440 | 06-12-2024 |
$25.7557 | $0 | $25.7557 | $0 | $0 | 1,395 | 06-03-2024 |
$25.7557 | $0 | $25.7557 | $0 | $0 | 44 | 05-15-2024 |
$25.7557 | $0 | $25.7557 | $0 | $0 | 50 | 05-09-2024 |
$25.7557 | $25.411 | $25.7557 | $25.7557 | $25.411 | 4,015 | 05-03-2024 |
$22.87 | $23.735 | $22.87 | $23.735 | $22.87 | 3,000 | 04-18-2024 |
$25 | $0 | $25 | $0 | $0 | 30 | 04-17-2024 |
$25 | $25 | $25 | $25 | $25 | 100 | 04-01-2024 |
$26.948 | $26.948 | $26.948 | $26.948 | $26.948 | 800 | 03-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Swedish Orphan Biovit Ord Company Name:
BIOVF Stock Symbol:
OTCMKTS Market:
WALTHAM, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced the presentation of three abstracts that highlights data from its myelofibrosis treatment option at the American Society of Clin...
WALTHAM, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation to emapalumab-lzsg being investigated as a pot...
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...